Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Medtronic
Johnson and Johnson
Mallinckrodt
Harvard Business School
Merck
Baxter

Last Updated: May 27, 2022

Investigational Drug Information for GDC-0077


✉ Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug GDC-0077?

GDC-0077 is an investigational drug.

There have been 188 clinical trials for GDC-0077. The most recent clinical trial was a Phase 3 trial, which was initiated on December 13th 2016.

The most common disease conditions in clinical trials are Breast Neoplasms, Carcinoma, and Lymphoma. The leading clinical trial sponsors are Genentech, Inc., National Cancer Institute (NCI), and Hoffmann-La Roche.

There are three US patents protecting this investigational drug and fifty-five international patents.

Recent Clinical Trials for GDC-0077
TitleSponsorPhase
Testing of Tazemetostat in Combination With Topotecan and Pembrolizumab in Patients With Recurrent Small Cell Lung CancerNational Cancer Institute (NCI)Phase 1
Testing the Safety and Efficacy of the Addition of A New Anti-cancer Drug, ZEN003694, to Chemotherapy Treatment (Etoposide and Cisplatin) for Adult and Pediatric Patients (12-17 Years) With NUT CarcinomaNational Cancer Institute (NCI)Phase 1/Phase 2
Circulating Tumor DNA Enriched, Genomically Directed Post-neoadjuvant Trial for Patients With Residual Triple Negative Breast CancerFoundation MedicinePhase 2

See all GDC-0077 clinical trials

Clinical Trial Summary for GDC-0077

Top disease conditions for GDC-0077
Top clinical trial sponsors for GDC-0077

See all GDC-0077 clinical trials

US Patents for GDC-0077

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
GDC-0077 See Plans and Pricing Benzoxazepin oxazolidinone compounds and methods of use Genentech, Inc. (South San Francisco, CA) See Plans and Pricing
GDC-0077 See Plans and Pricing Benzoxazepin oxazolidinone compounds and methods of use Genentech, Inc. (South San Francisco, CA) See Plans and Pricing
GDC-0077 See Plans and Pricing Benzoxazepin oxazolidinone compounds and methods of use Genentech, Inc. (South San Francisco, CA) See Plans and Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Johnson and Johnson
Mallinckrodt
Harvard Business School
Merck
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.